Spruce Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Spruce Biosciences

10/08/2022 21:50

* Spruce Biosciences Inc  SPRB.OQ  reported a quarterly
adjusted
loss of 51 cents​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 52 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Spruce Biosciences Inc's reported EPS for the quarter was
a loss
of 51 cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Spruce Biosciences Inc shares had risen by 11.5% this
quarter and lost 56.5% so far this year.
    * The company reported a quarterly loss of $11.87 million.
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 08:49 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.52          -0.51          Beat
 Mar. 31 2022      -0.46          -0.50          Missed
 Dec. 31 2021      -0.54          -0.39          Beat
 Sep. 30 2021      -0.57          -0.49          Beat